Stable Chronic Obstructive Pulmonary Disease (COPD) Management Under a Tiered Medical System in China

被引:4
|
作者
Mao, Ruolin [1 ]
Liu, Zilong [1 ]
Zhao, Yunfeng [2 ]
Du, Chunlin [3 ]
Zhou, Jintao [4 ]
Wang, Qian [5 ]
Lu, Jinchang [3 ]
Gao, Lei [1 ]
Cui, Bo [1 ]
Ma, Yuan [1 ]
Sun, Tieying [6 ]
Zhu, Lei [1 ,7 ]
Chen, Zhihong [1 ]
机构
[1] Fudan Univ, Zhongshan Hosp, Dept Resp & Crit Care Med, Shanghai Inst Resp Dis, Shanghai, Peoples R China
[2] Punan Hosp, Dept Resp Dis, Pudong New Area, Shanghai, Peoples R China
[3] Fudan Univ, Dept Resp & Crit Care Med, Qingpu Branch, Zhongshan Hosp, Shanghai, Peoples R China
[4] Soochow Univ, Dept Resp & Crit Care Med, Taicang Hosp, Taicang, Jiangsu, Peoples R China
[5] Jingan Dist Zhabei Cent Hosp, Dept Resp Med, Shanghai, Peoples R China
[6] Beijing Hosp, Natl Ctr Gerontol, Dept Resp & Crit Care Med, Beijing, Peoples R China
[7] Beijing Tsinghua Changgung Hosp, Dept Resp & Crit Care Med, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
stable chronic obstructive pulmonary disease; tiered medical system; airflow limitation; symptoms; acute exacerbation; POSITIVE-PRESSURE VENTILATION; OXYGEN-THERAPY;
D O I
10.2147/COPD.S333274
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Early diagnosis and proper management of a large number of chronic obstructive pulmonary disease (COPD) patients are great challenges for the Chinese health care system. Although tiered medical services have been promoted by the Chinese government since 2015, they have not been ideally implemented for COPD diagnosis and management. Patients and Methods: We designed a cross-sectional study. Eligible COPD patients (n = 648) and physicians (n = 161) were consecutively recruited from 8 hospitals in different tiers in China. COPD characteristics and treatments were compared among hospitals in different tiers. Multivariate logistic regression was performed to identify risk factors associated with airflow limitation, symptoms and acute exacerbation. Results: The PFT rate at first diagnosis was 99%, 69.4% and 29.9% in teaching, second-tier and community hospitals (P < 0.001). Only approximately 10.9%, 1.7% and 9.6% and 21.8%, 6.9% and 32% of COPD patients received influenza or pneumococcal vaccines (P < 0.001). The proportion of patients who did not use inhaled drugs or had irregular inhalation was 2%, 24.6% and 78.8% (P < 0.001). Education level (RR-1 = -41.26%, P = 0.007), FEV1%pred (RR-1 = -2.76%, P < 0.001), and influenza vaccination in the last year (RR-1 = -64.53%, P = 0.006) were all negatively correlated with COPD acute exacerbation (AE). COPD duration (RR-1 = 131.73%, P = 0.009), AE (RR-1 = 151.39%, P < 0.001), and COPD Assessment Test (CAT) scores (RR-1 = 3.82%, P = 0.019) were all positively correlated with COPD airflow limitation severity. Conclusion: Differences exist in the diagnosis, treatment and management of COPD among different tiers of hospitals in China. Teaching hospitals can manage COPD patients relatively well. There are still some gaps compared with developed countries.
引用
收藏
页码:181 / 194
页数:14
相关论文
共 50 条
  • [1] Management of acute exacerbation of chronic obstructive pulmonary disease under a tiered medical system in China
    Liu, Xiaojing
    Du, Chunling
    Hu, Fuying
    Zhao, Yunfeng
    Zhou, Jintao
    Wang, Qian
    Mu, Yutong
    Lu, Jinchang
    Gao, Lei
    Cui, Bo
    Ma, Yuan
    Sun, Tieying
    Qian, Feng
    Chen, Zhihong
    [J]. THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2022, 16
  • [2] Management of acute exacerbation of chronic obstructive pulmonary disease under a tiered medical system in China
    Liu, Xiaojing
    Du, Chunling
    Hu, Fuying
    Zhao, Yunfeng
    Zhou, Jintao
    Wang, Qian
    Mu, Yutong
    Lu, Jinchang
    Gao, Lei
    Cui, Bo
    Ma, Yuan
    Sun, Tieying
    Qian, Feng
    Chen, Zhihong
    [J]. THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2022, 16
  • [3] Therapeutic options in the management of stable chronic obstructive pulmonary disease (COPD)
    Schäfer, H
    Ewig, S
    Gillissen, A
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2000, 125 (08) : 230 - 235
  • [4] Management of Stable Chronic Obstructive Pulmonary Disease
    Fu, Danny
    Lapreze, Jennifer
    [J]. US PHARMACIST, 2013, 38 (07) : 43 - 46
  • [5] Chronic obstructive pulmonary disease • 7:: Management of COPD
    MacNee, W
    Calverley, PMA
    [J]. THORAX, 2003, 58 (03) : 261 - 265
  • [6] Updates in the management of stable chronic obstructive pulmonary disease
    Narsingam, Saiprasad
    Bozarth, Andrew L.
    Abdeljalil, Asem
    [J]. POSTGRADUATE MEDICINE, 2015, 127 (07) : 758 - 770
  • [7] Update on management of stable chronic obstructive pulmonary disease
    Agrawal, Ritwick
    Moghtader, Shahram
    Ayyala, Uma
    Bandi, Venkata
    Sharafkhaneh, Amir
    [J]. JOURNAL OF THORACIC DISEASE, 2019, 11 : S1800 - S1809
  • [8] Management of acute exacerbation of chronic obstructive pulmonary disease (COPD)
    Gillissen, A
    Buhl, R
    Kardos, P
    Kenn, K
    Matthys, H
    Pfister, R
    Rabe, KF
    Sauer, R
    Vogelmeier, C
    Wettengel, R
    Worth, H
    Menz, G
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2003, 128 (33) : 1721 - 1727
  • [9] Chronic obstructive pulmonary disease (COPD)
    Pahl, Andreas
    Szelenyi, Istvan
    [J]. DRUGS OF THE FUTURE, 2007, 32 (09) : 799 - 807
  • [10] Chronic Obstructive Pulmonary Disease (COPD)
    Gillissen, Adrian
    Rasche, Kurt
    [J]. MEDIZINISCHE KLINIK, 2006, 101 (07) : 559 - 570